DS
OMGA

David Shaw’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

David Shaw’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,327
Closed -$58K – 5598
2022
Q2 		$58K Buy
15,327
+1,890
+14% +$7.04K ﹤0.01% 4820
2022
Q1 		$84K Buy
+13,437
New +$137K ﹤0.01% 5036

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

David Shaw's OMGA Position: Q3 2022 in Review

David Shaw sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q3 2022, closing a stake of 15,327 shares — an estimated $58K sold.

David Shaw first reported a position in OMGA in Q1 2022 and held it in 2 quarters. The position peaked at $84K in Q1 2022. 44 funds tracked by Wall St. Rank hold OMGA as of Q3 2022.

  • David Shaw reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 15,327 Omega Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $58K.
  • David Shaw first reported a position in Omega Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • David Shaw's Omega Therapeutics, Inc. Common Stock position peaked at $84K in Q1 2022.
  • 44 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.